Should a Patient with History of PE 2 Years Ago Use Sequential Compression Devices?
No, a patient with a history of PE from 2 years ago does not require routine use of sequential compression devices (SCDs) unless they are currently hospitalized, non-ambulatory, or undergoing surgery with additional acute VTE risk factors.
Clinical Context and Risk Assessment
A PE that occurred 2 years ago is a remote event, and the patient is no longer in the acute or extended treatment phase. The key question is whether this patient currently has active VTE risk requiring mechanical prophylaxis:
SCDs are indicated for acute VTE prevention during hospitalization, particularly in non-ambulatory patients or those undergoing surgery, not for chronic secondary prevention in ambulatory outpatients 1, 2.
The 2021 CHEST guidelines address extended-phase anticoagulation decisions but do not recommend mechanical prophylaxis devices like SCDs for long-term outpatient VTE prevention 3.
Historical PE alone does not justify ongoing SCD use in an ambulatory patient who has completed their treatment course and returned to normal activity.
When SCDs Are Actually Beneficial
SCDs demonstrate clear benefit in specific high-risk scenarios:
Non-ambulatory hospitalized patients: In stroke patients, adding SCDs to subcutaneous heparin reduced DVT risk by more than 40-fold compared to heparin alone (0.23% vs 9.2% DVT rate) 1.
Cardiac surgery patients: Combined SCD and subcutaneous heparin reduced postoperative PE by 62% compared to heparin alone (1.5% vs 4% PE rate) 2.
Surgical procedures lasting ≥30 minutes in patients with multiple comorbidities show benefit from SCD prophylaxis 4.
Evidence Against Routine SCD Use
Recent evidence questions routine SCD use even in hospitalized settings:
Medically ill hospitalized patients: A 2019 study of over 30,000 patients found no significant difference in VTE incidence with SCDs compared to no thromboprophylaxis (OR 0.99,95% CI 0.57-1.73) 5.
Enhanced recovery protocols: In thoracic surgery patients following ERAS protocols, routine SCD use showed minimal benefit with only 2 PEs occurring in the SCD group, both after hospital discharge, raising questions about their prophylactic value 6.
Practical Recommendation Algorithm
For your patient with remote PE history:
If ambulatory and outpatient: No SCDs needed. Focus on addressing modifiable risk factors and consider extended anticoagulation only if unprovoked PE or ongoing risk factors 3.
If currently hospitalized and non-ambulatory: Use SCDs in combination with pharmacologic prophylaxis (unless contraindicated) 1.
If undergoing surgery: Apply SCDs perioperatively, especially for procedures >30 minutes, and continue until fully ambulatory 2, 4.
If hospitalized but ambulatory: SCDs likely unnecessary; early mobilization and pharmacologic prophylaxis are preferred 6, 5.
Key Caveats
SCDs are adjunctive, not primary prevention: They work best when combined with pharmacologic prophylaxis in appropriate patients 1, 2.
The 2026 AHA/ACC/ACCP guidelines focus on acute PE management and risk stratification but do not advocate for chronic mechanical prophylaxis in stable outpatients 7.
Remote VTE history requires assessment of current risk: A PE 2 years ago places the patient at higher baseline risk for recurrence, but this is addressed through anticoagulation decisions, not mechanical devices 3.